Although its only October and those of us with children (Max is 7 months old now) are eagerly awaiting a fun filled Halloween, 2016 has already been a remarkable year both personally and for ArcheMedX in terms of customer growth, product evolution, educational impact, and ground breaking research. To elaborate on these highlights (and more) we have invited industry partners and interested parties to attend a brief Webinar.

The one-hour session will provide an update on our progress and plans for the future, covering the following topics:

If you are interested in joining us, please register for one of two upcoming Webinar dates:

ArcheMedX has now powered nearly 350 Activities for 20+ Education Partners, receiving grant support from 30+ Commercial Supporters (i.e., pharmaceutical firms). These Activities have enabled more than 15,000 Learners (primarily clinicians) to take 40,000 Learning Actions (i.e., notes, reminders, searches, responding to faculty nudges, etc). Thanks to the medical education community’s vision, planning, support, and collaborative efforts, we continue to grow!

Recently launched Activities include Zika education, AAP’s annual Influenza curriculum, a Clinical Trials curriculum with UVA, a Patient Safety curriculum with UNTHSC, an expanded PCMH team-based learning experience with NCQA, and dozens of additional Activities in topics ranging from cardiology, to oncology, to rheumatology, to neurology, to endocrinology, and many, many more!